Healthcare Triangle (NASDAQ:HCTI – Get Free Report) is one of 93 publicly-traded companies in the “Healthcare Technology” industry, but how does it contrast to its rivals? We will compare Healthcare Triangle to related businesses based on the strength of its risk, dividends, earnings, valuation, institutional ownership, analyst recommendations and profitability.
Insider and Institutional Ownership
0.3% of Healthcare Triangle shares are held by institutional investors. Comparatively, 42.4% of shares of all “Healthcare Technology” companies are held by institutional investors. 0.1% of Healthcare Triangle shares are held by company insiders. Comparatively, 16.2% of shares of all “Healthcare Technology” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Analyst Ratings
This is a breakdown of current ratings and recommmendations for Healthcare Triangle and its rivals, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Healthcare Triangle | 1 | 0 | 0 | 0 | 1.00 |
| Healthcare Triangle Competitors | 455 | 1537 | 2754 | 89 | 2.51 |
As a group, “Healthcare Technology” companies have a potential upside of 45.79%. Given Healthcare Triangle’s rivals stronger consensus rating and higher probable upside, analysts clearly believe Healthcare Triangle has less favorable growth aspects than its rivals.
Earnings & Valuation
This table compares Healthcare Triangle and its rivals revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Healthcare Triangle | $13.89 million | -$9.48 million | -0.01 |
| Healthcare Triangle Competitors | $343.89 million | -$24.15 million | 12.79 |
Healthcare Triangle’s rivals have higher revenue, but lower earnings than Healthcare Triangle. Healthcare Triangle is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Risk and Volatility
Healthcare Triangle has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500. Comparatively, Healthcare Triangle’s rivals have a beta of 1.11, meaning that their average stock price is 11% more volatile than the S&P 500.
Profitability
This table compares Healthcare Triangle and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Healthcare Triangle | -45.37% | -79.75% | -24.14% |
| Healthcare Triangle Competitors | -749.77% | -28.38% | -15.05% |
Summary
Healthcare Triangle rivals beat Healthcare Triangle on 10 of the 13 factors compared.
Healthcare Triangle Company Profile
Healthcare Triangle, Inc. provides technology and consulting services to healthcare and life sciences organizations. Its work includes helping clients modernize cloud systems, manage and analyze data, connect disparate health information systems, and address cybersecurity and regulatory-compliance needs. The company offers solutions under the CloudEz, DataEz and InteropX names, covering cloud services, data management and interoperability. It also provides implementation, consulting and ongoing technology support.
Receive News & Ratings for Healthcare Triangle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Triangle and related companies with MarketBeat.com's FREE daily email newsletter.
